TUCSON, Ariz.--(EON: Enhanced Online News)--SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the world’s first three Total Artificial Heart patients have been discharged from SynCardia Certified Centers using the new Freedom™ portable driver. Weighing 13.5 lbs, the Freedom driver is the world’s first wearable portable driver designed to power SynCardia’s Total Artificial Heart both inside and outside the hospital.
“The patient received a matching donor heart three days later and is in good condition.”
1st European Patient - Nantes, France
World’s 1st Female Patient - Moscow, Russia
1st U.S. Participant in IDE Clinical Study - Phoenix, Arizona
The Freedom driver has the CE Mark for use in Europe and has received conditional approval from the FDA to undergo an IDE clinical study in the U.S.
Quantin (Nantes, France)
Tatyana (Moscow, Russia)
Charles Okeke (Phoenix, Arizona, U.S.)
Freedom™ portable driver and Big Blue hospital driver
Freedom™ portable driver and Total Artificial Heart
About SynCardia Systems, Inc.
SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 190 patient years of life on the device.
Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles.